thehill.com

thehill.com
Share

thehill.com

 •  October 11

Doctors and hospitals are increasingly being paid not for the quantity of care they provide, but for the outcome or quality of care patients receive. The emerging trend in health care is about rewarding value, rather than volume. This is the future, where there is less focus on the number of tests or treatments a patient receives and more focus on...

thehill.com

 •  September 30

The Trump administration this week delayed the implementation of a rule under the Affordable Care Act meant to punish drug companies for price gouging, according to a new report. The Department of Health and Human Services (HHS) on Thursday quietly logged the delayed rollout of the rule into the federal register, Mic reports. The rule was initially...

thehill.com

 •  September 29

A recent study makes the bold claim that the most generally accepted estimate of the cost of drug development is overstated by a factor of almost 2:1. This would be important news, if it were accurate. The study examined 10 cancer drugs from 10 pharmaceutical companies over a period of nine years. Using data available from public filings, the study...

thehill.com

 •  September 27

A powerful drug industry trade group announced its support for limiting a patient’s supply of opioids to seven days for first time acute pain treatment, as a way to curb the opioid epidemic plaguing the country. “Too often individuals receive a 30-day supply of opioid medicines for minor treatments or short-term pain,” Stephen Ubl, president and...

thehill.com

 •  September 15

Despite growing public health concerns and focus on the issue, opioid therapy remains an important piece of the puzzle for many patients receiving treatment for chronic pain. However, the inherent risks associated with opioid therapy are a major public safety issue plaguing today’s society, breaking families apart, and contributing to the more than...

thehill.com

 •  September 6

We should have seen the drug price crisis coming. Over thirty years ago Robert Bork, chief architect of modern antitrust law, warned “predation by abuse of government procedures, including administrative and judicial procedures, presents an increasingly dangerous threat to competition.” Bork devoted an entire chapter of his seminal book, The...

thehill.com

 •  September 6

A major pharmaceutical company lied and bypassed normal processes to push opioids on to patients who didn't need them, according to a new report released Wednesday by Sen. Claire McCaskill (D-Mo.) The report is the first product of an investigation into opioid manufacturers and distributors led by McCaskill in her role as the ranking Democrat on...

thehill.com

 •  June 30

Congress will update the laws governing prescription drugs this summer, including changes to a program designed to spur drug development for neglected diseases like dengue, Ebola, Zika and river blindness. Unfortunately, the fix as written to the FDA Reauthorization Act does too little to help the millions of people at risk for these diseases. A...

thehill.com

 •  May 8

The importation of prescription drugs from foreign markets has emerged as a quick-fix proposal to enhance affordability and patient access. Supporters believe the fundamental goal is laudable, however, the risks far outweigh the benefits. Importation would threaten and destabilize the significant industry-government collaboration already underway...

thehill.com

 •  May 6

Colon cancer is one of the biggest killers in the developing world. The disease claims more than 600,000 lives every year. Breakthrough treatments can contain this disease and dramatically extend life. However, many colon cancer patients are currently denied access to these breakthrough treatments because of short-sighted government policies. In...